Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

China Denies Breaking Trade Truce as U.S.-China Tensions Escalate

by Team Lumida
June 2, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Manufacturing Powerhouse Faces Domestic Struggles: What It Means for Global Investors

"MY ROAD : FLAG OF CHINA" by Lαin is licensed under CC BY-NC-ND 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • China rejected President Trump’s accusations of violating a trade truce, claiming it upheld the Geneva consensus while accusing the U.S. of undermining the agreement with restrictive measures.
  • Tensions have flared over issues such as U.S. export controls on AI chips, visa restrictions for Chinese students, and China’s rare-earth mineral exports.
  • Trump reiterated his accusations, stating he plans to discuss the matter with Chinese President Xi Jinping.
  • The breakdown in progress toward a deal has rattled markets, with Hong Kong’s Hang Seng Index falling 2.2% and the Hang Seng Tech Index dropping 2.4%.

What Happened?

China’s Commerce Ministry pushed back against President Trump’s claims that Beijing violated a trade truce reached in mid-May during talks in Geneva. The agreement had temporarily lowered tariffs, offering a brief reprieve to global markets.

In a statement, China accused the U.S. of undermining the consensus by introducing “discriminatory and restrictive measures,” including export controls on AI chips and visa revocations for Chinese students. Trump, however, accused China of violating “a big part of the agreement” and expressed his intention to discuss the issue with Chinese President Xi Jinping.

The renewed tensions have dampened optimism for a lasting trade deal, with markets reacting negatively. Chinese stocks in Hong Kong fell sharply, led by declines in the Hang Seng Index and Hang Seng Tech Index.


Why It Matters?

The re-escalation of U.S.-China trade tensions highlights the fragility of the temporary truce and the challenges in reaching a lasting agreement. Key issues, such as technology export controls and rare-earth mineral exports, remain contentious, further complicating negotiations.

The market reaction underscores the economic stakes of the ongoing trade dispute. Declines in Chinese equities reflect investor concerns about the potential for prolonged uncertainty and its impact on global trade and economic growth.

Trump’s accusations and China’s counterclaims also signal a deepening mistrust between the two superpowers, raising questions about the feasibility of resolving broader geopolitical and economic tensions.


What’s Next?

President Trump’s planned discussion with Chinese President Xi Jinping will be closely watched for signs of progress or further escalation. Meanwhile, markets will monitor developments in U.S.-China relations, including potential retaliatory measures from Beijing.

Investors will also keep an eye on the impact of U.S. export controls and visa restrictions, as well as China’s response to Trump’s threat to double tariffs on steel and aluminum imports. The outcome of these disputes will shape the trajectory of global markets and trade dynamics in the coming months.

Source
Tags: China
Previous Post

Corporate Pension Funds Shift Strategies Amid Full Funding, Impacting Bonds and Private Equity

Next Post

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Recommended For You

Iran’s Nuclear Arsenal Survived the Bombs — And That’s Washington’s Biggest Problem

by Team Lumida
5 hours ago
Why Iran Thinks It Won the War — Despite Catastrophic Military Losses

Five weeks of U.S. and Israeli strikes destroyed facilities but left Iran's uranium stockpile and centrifuges intact, as Islamabad peace talks collapse after 21 hours.

Read more

Peace Talks Collapse: Trump Orders a U.S. Blockade of the Strait of Hormuz Starting Monday

by Team Lumida
5 hours ago
Iran’s Island Fortress: The Five Strategic Positions Holding Hormuz Hostage

After 21 hours of failed talks in Islamabad, Trump announced the U.S. Navy will blockade the Strait of Hormuz at 10 a.m. Monday — interdicting vessels that paid...

Read more

Trump Attacks Pope Leo: ‘Stop Catering to the Radical Left and Focus on Being a Great Pope’

by Team Lumida
5 hours ago
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

Trump publicly feuded Sunday with Pope Leo XIV — an American — after the pontiff condemned the Iran war, called Trump's civilization threat 'truly unacceptable,' and told Catholic...

Read more

Iran Still Has Thousands of Missiles — and Intelligence Says It Can Get More Out of the Ground

by Team Lumida
2 days ago
Why Iran Thinks It Won the War — Despite Catastrophic Military Losses

Despite Hegseth declaring Iran's missile program 'functionally destroyed,' U.S. intelligence assessments tell a more complicated story: Iran retains thousands of ballistic missiles it can retrieve from underground storage,...

Read more

White House Sent Staff-Wide Email Warning Against Insider Trading on Iran War Bets

by Team Lumida
3 days ago
White House, Washington DC

The White House Management Office sent a confidential staff-wide email on March 24 warning employees not to use government information for financial gain — one day after oil...

Read more

The ‘Busan Freeze’: How Trump Quietly Abandoned His Tough-on-China Playbook

by Team Lumida
3 days ago
China’s Bold Economic Moves: What You Need to Know Now

A WSJ investigation reveals Trump 2.0 has paused tariffs, shelved tech bans, sidelined China hawks, and told agencies to stop naming China in threat bulletins — a sweeping...

Read more

Trump Asks Netanyahu to Scale Back Lebanon War to Save Iran Ceasefire Talks

by Team Lumida
3 days ago
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

Hours after announcing the Iran ceasefire, Israel launched ~100 simultaneous strikes killing 300+ in Lebanon — forcing Trump to call Netanyahu and demand he be 'more low-key' before...

Read more

Trump Eyes Punishment for NATO Allies That Sat Out the Iran War

by Team Lumida
4 days ago
Supreme Court Signals It Will Strike Down Trump’s Birthright Citizenship Order

The White House is circulating a plan to move U.S. troops out of NATO countries — potentially including Spain and Germany — that blocked or restricted base access...

Read more

Why Iran Thinks It Won the War — Despite Catastrophic Military Losses

by Team Lumida
4 days ago
Why Iran Thinks It Won the War — Despite Catastrophic Military Losses

Iran emerged from 38 days of war with the U.S. and Israel having survived, retained control of the Strait of Hormuz, and established a new deterrence — and...

Read more

Iran Tightens Its Grip on Hormuz Despite the Ceasefire — Charging Tolls and Limiting Traffic

by Team Lumida
4 days ago
Iran Tightens Its Grip on Hormuz Despite the Ceasefire — Charging Tolls and Limiting Traffic

Despite Trump's demand for a 'complete, immediate, and safe' reopening of the Strait of Hormuz, Iran's Revolutionary Guard is asserting continued control — restricting ship traffic, requiring Iranian...

Read more
Next Post
Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

AI Investment Boom: How Tech Giants Are Leading the Charge

AI Models Show Alarming Ability to Evade Human Control, Highlighting Urgent Need for Alignment Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

woman wearing black sports bra

Inside Equinox’s Elite $40,000 Longevity Program: What You Need to Know

May 17, 2024
Tim Cook Rallies Apple Staff on AI Ambitions and Product Pipeline After Earnings Beat

Tim Cook Rallies Apple Staff on AI Ambitions and Product Pipeline After Earnings Beat

August 2, 2025
Trump Pushes for Greenland Acquisition, Exploring Business Deals and Military Presence

Trump Pushes Emergency PJM Auction to Make Tech Giants Underwrite New Power Plants

January 16, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018